Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids

No abstract is available for this paper.

• Publication year

  1988

• Venue

  International Journal of Cancer

• Publication date

  1988-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.2910420622PMID 3263955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP

  1988cited by this paper
• Receptors for epidermal growth factor and other polypeptide mitogens.

  1987cited by this paper
• Prostatic epidermal growth factor receptors and their regulation by androgens.

  1987cited by this paper
• Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.

  1987cited by this paper
• Characterization of androgen receptors in a transplantable human prostatic adenocarcinoma (PC‐82)

  1987cited by this paper
• Assay of oestrogen and progestin receptors in human meningioma cytosols using immunological methods.

  1987cited by this paper
• Growth regulation of human breast carcinoma occurs through regulated growth factor secretion

  1987cited by this paper
• Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.

  1987cited by this paper
• Androgen‐dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP

  1986cited by this paper
• Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice.

  1986cited by this paper
• Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.

  1986cited by this paper
• Androgen‐repressed messages in the rat ventral prostate

  1986cited by this paper
• Regulation of epidermal growth factor receptor by estrogen.

  1985cited by this paper
• Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP‐r

  1985cited by this paper
• Hormone dependency of a serially transplantable human prostatic cancer (HONDA) in nude mice.

  1985cited by this paper
• Androgen regulated genes from prostate and seminal vesicle share upstream sequence homologies.

  1985cited by this paper
• Regulation of prostatic steroid binding protein mRNAs by testosterone.

  1985cited by this paper
• Purification and characterization of vaccinia virus growth factor.

  1985cited by this paper
• Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells

  1984cited by this paper
• Nuclear localization of unoccupied oestrogen receptors

  1984cited by this paper
• Identification of epidermal growth factor-like activity in human male reproductive tissues and fluids.

  1984cited by this paper
• Rat transforming growth factor type 1: structure and relation to epidermal growth factor.

  1984cited by this paper
• Regulation of high- and low-affinity epidermal growth factor receptors by glucocorticoids.

  1984cited by this paper
• LNCaP model of human prostatic carcinoma.

  1983cited by this paper
• Models for prostate cancer.

  1980cited by this paper
• Autocrine secretion and malignant transformation of cells.

  1980cited by this paper
• Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

  1979cited by this paper
• Epidermal growth factor.

  1979cited by this paper
• Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431.

  1978cited by this paper
• Epidermal growth factor

  1972cited by this paper
• An improved fluorometric assay for DNA.

  1971cited by this paper
• Production of transforming growth factor a in human pancreatic cancer cells: Evidence for a superagonist autocrine cycle

  year unknowncited by this paper

• Sex hormone-binding globulin and its critical role in prostate cancer: A comprehensive review.

  2024cites this paper
• Multifunctionality of Prostatic Acid Phosphatase in Prostate  Cancer Pathogenesis.

  2021cites this paper
• Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis

  2021cites this paper
• Androgen-induced Epigenetic Profiles of Polycomb and Trithorax Genes in Prostate Cancer Cells

  2020cites this paper
• Étude des implications biochimiques et moléculaires sous-jacentes à la pharmacothérapie ciblée contre la proprotéine convertase PACE4 dans le cancer de la prostate

  2018cites this paper
• Enzalutamide in the Treatment of Patients with Metastatic Castrate-Resistant Prostate Cancer

  2017cites this paper
• Systems Pharmacology Modeling of Prostate‐Specific Antigen in Patients With Prostate Cancer Treated With an Androgen Receptor Antagonist and Down‐Regulator

  2016cites this paper
• Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression

  2016cites this paper
• Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer.

  2016cites this paper
• Enzalutamide (Xtandi): An Androgen Receptor Antagonist for Late‐Stage Prostate Cancer

  2015cites this paper
• Cell surface effects of androgens between 1 pM and 100 nM on rat sertoli cells and two human prostatic cell lines, LNCaP and PC3: evidence for two membrance receptors

  2015cites this paper
• Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer

  2015cites this paper
• Androgen-Responsive Gene Expression in Prostate Cancer Progression

  2013cites this paper
• PHOSPHORYLATION OF THE ANDROGEN RECEPTOR IN A HUMAN PROSTATE TUMOR CELL LINE FOSFORYLERING VAN DE ANDROGEEN RECEPTOR IN EEN HUMANE PROSTAAT TUMOR CELLIJN PROEFSCHRIFT

  2013cites this paper
• Role of proprotein convertases in prostate cancer progression.

  2012cites this paper
• Synthesis and biological activity of ferrocenyl derivatives of the non-steroidal antiandrogens flutamide and bicalutamide

  2011cites this paper
• Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC).

  2010cites this paper
• Effects of the androgen receptor overexpression in prostate cancer

  2007cites this paper
• 17β‐estradiol differentially regulates androgen‐responsive genes through estrogen receptor‐β‐ and extracellular‐signal regulated kinase‐dependent pathways in LNCaP human prostate cancer cells

  2007influential citation
• Molecular mechanisms of androgen receptor functions

  2007cites this paper
• Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells

  2007cites this paper
• 17beta-Estradiol differentially regulates androgen-responsive genes through estrogen receptor-beta- and extracellular-signal regulated kinase-dependent pathways in LNCaP human prostate cancer cells.

  2007cites this paper
• The Human Prostatic Carcinoma Cell Line LNCaP Expresses Biologically Active, Specific Receptors for la,25-Dihydroxyvitamin Ãœ31

  2006cites this paper
• Androgen Receptor Activation in Prostatic Tumor Cell Lines by Insulin-like Growth Factor-I, Keratinocyte Growth Factor, and Epidermal Growth Factor1

  2006cites this paper
• Genistein affects androgen‐responsive genes through both androgen‐ and estrogen‐induced signaling pathways

  2006cites this paper
• Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.

  2005cites this paper
• Cluster-analysis of androgen- and EGF-regulated genes in relation to the proliferation and invasion of prostate cancer cells

  2005cites this paper
• Identification of steroid derivatives that function as potent antiandrogens

  2005cites this paper
• Secretoglobin 2A1 is under selective androgen control mediated by a peculiar binding site for Sp family transcription factors.

  2005cites this paper
• Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression

  2004cites this paper
• Growth factors as mediators of androgen action during the development of the male urogenital tract

  2004cites this paper
• 5α-Androstane-3α,17β-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer LNCaP cell proliferation

  2004cites this paper
• 5alpha-Androstane-3alpha,17beta-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer LNCaP cell proliferation.

  2004cites this paper
• A bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron.

  2004cites this paper
• New perspectives on growth factor-sex steroid interaction in the prostate.

  2003cites this paper
• Polymorphisms of estrogen receptor alpha in prostate cancer

  2003cites this paper
• The response of extracellular signal-regulated kinase (ERK) to androgen-induced proliferation in the androgen-sensitive prostate cancer cell line, LNCaP

  2003cites this paper
• Androgen receptors in prostate cancer.

  2003cites this paper
• Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

  2003cites this paper
• 3β-Acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity

  2003cites this paper
• The Gene Encoding Human SCGB 2A1 is under Indirect Androgen Control Operating through an Sp Family Binding Site in Prostate Cells

  2003cites this paper
• Androgen receptors in prostate cancer.

  2002cites this paper
• Estrogens affect endothelin-1 mRNA expression in LNCaP human prostate carcinoma cells.

  2002cites this paper
• Androgen and retinoic acid interaction in LNCaP cells, effects on cell proliferation and expression of retinoic acid receptors and epidermal growth factor receptor

  2002cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2002cites this paper
• Steroid Receptor and Enzyme Abnormalities ANDROGEN RECEPTOR ABNORMALITIES

  2002cites this paper
• Dihydrotestosterone (DHT) modulates the ability of NSAIDs to induce apoptosis of prostate cancer cells

  2002cites this paper
• Endocrine-Related Cancer ( 2002 ) 9 155 – 170 Androgen receptors in prostate cancer

  2002cites this paper
• Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer

  2002cites this paper
• Nonandrogenic mediators of prostatic growth.

  2001cites this paper
• The Androgen Receptor

  2001cites this paper
• Expression of Estrogen Receptor (ER–α and ER–β) mRNA in Human Prostate Cancer

  2001cites this paper
• Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer.

  2001influential citation
• Transforming Growth Factor+31 Is a Mediator of Androgen-Regulated Growth Arrest in an Androgen-Responsive Prostatic Cancer Cell Line, LNCaP*

  2001cites this paper
• Expression of estrogen receptor (ER-alpha and ER-beta) mRNA in human prostate cancer.

  2001cites this paper
• Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

  2000cites this paper
• The role of receptors in prostate cancer.

  2000cites this paper
• Advances in Brief PART-1 : A Novel Human Prostate-specific , Androgen-regulated Gene that Maps to Chromosome 5 q 121

  2000cites this paper
• Rapid Androgen Actions on Calcium Signaling in Rat Sertoli Cells and Two Human Prostatic Cell Lines: Similar Biphasic Responses Between 1 Picomolar and 100 Nanomolar Concentrations1

  2000cites this paper
• PART-1: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12.

  2000cites this paper
• Expression and function of androgen receptor in carcinoma of the prostate

  2000cites this paper
• Prostate cancer schemes for androgen escape

  2000cites this paper
• Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications

  2000cites this paper
• Inhibition of prostate specific antigen expression by genistein in prostate cancer cells.

  2000cites this paper
• Estrogens increase the endothelial nitric oxide synthase (ecNOS) mRNA level in LNCaP human prostate carcinoma cells

  2000cites this paper
• Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor.

  2000cites this paper
• Partial and Generalized Seizures Affect Reproductive Physiology Differentially in the Male Rat

  1999cites this paper
• Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

  1999cites this paper
• Molecular action of androgen in the normal and neoplastic prostate.

  1999cites this paper
• Androgens down-regulate the expression of the human homologue of paternally expressed gene-3 in the prostatic adenocarcinoma cell line LNCaP.

  1999cites this paper
• Retinoid and androgen regulation of cell growth, epidermal growth factor and retinoic acid receptors in normal and carcinoma rat prostate cells.

  1999cites this paper
• The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells

  1999cites this paper
• Androgenic regulation of growth factor and growth factor receptor expression in the cwr22 model of prostatic adenocarcinoma

  1999cites this paper
• Identification of the Phosphatidic Acid Phosphatase Type 2a Isozyme as an Androgen-regulated Gene in the Human Prostatic Adenocarcinoma Cell Line LNCaP*

  1998cites this paper
• Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.

  1998cites this paper
• Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.

  1998cites this paper
• Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells.

  1998cites this paper
• Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors

  1998cites this paper
• Structure and Expression of the Androgen Receptor in Prostate Cancer

  1998cites this paper
• Mechanism of invasion by prostate cancer

  1998influential citation
• Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line

  1998cites this paper
• Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.

  1997cites this paper
• Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells.

  1997influential citation
• Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro.

  1997cites this paper
• Endocrine Disruptors: Effects on Sex Steroid Hormone Receptors and Sex Development

  1997cites this paper
• Advances in understanding mechanisms of birth defects : mechanistic understanding of human developmental toxicants

  1997cites this paper
• Androgen-regulated gene expression in prostate cancer.

  1997cites this paper
• Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.

  1997cites this paper
• Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications

  1997cites this paper
• Androgens are not a direct requirement for the proliferation of human prostatic epithelium in vitro

  1997cites this paper
• Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.

  1997cites this paper
• The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease.

  1997cites this paper
• Bicalutamide ('Casodex') development: from theory to therapy.

  1997cites this paper
• Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis

  1996cites this paper
• The effects of dihydrotestosterone on the expression of p185(erbB-2) and c-erbB-2 mRNA in the prostatic cell line LNCaP.

  1996cites this paper
• Epidermal growth factor, epidermal growth factor receptor, and transforming growth factor-alpha in human hyperplastic prostate tissue: expression and cellular localization.

  1996cites this paper
• Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer.

  1996cites this paper
• Action, localization and structure-function relationship of growth factors and their receptors in the prostate

  1996cites this paper
• Codon 877 Mutation in the Androgen Receptor Gene in Advanced Prostate Cancer: Relation to Antiandrogen Withdrawal Syndrome

  1996cites this paper
• Regulation of prostatic growth and function by peptide growth factors

  1996cites this paper